FCU-08

**FCU-08** is a Fuso Pharmaceutical Industries development-stage artificial dialysis and substitution fluid intended for continuous renal replacement therapy in adults with acute kidney injury requiring continuous blood purification. It was evaluated for use as dialysate and/or replacement fluid during continuous hemofiltration or continuous hemodiafiltration, with Sublood-BSG as the active comparator. FCU-08 is a supportive renal-replacement therapy product rather than a molecularly targeted drug; its intended clinical role is to support extracorporeal fluid, electrolyte, and acid-base management during continuous blood purification.